We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.63%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
201
Oxford Asset Management
United Kingdom
$758K +$686K +13,927 New
TMAM
202
Tokio Marine Asset Management
Japan
$757K +$685K +13,900 New
VOYA Investment Management
203
VOYA Investment Management
Georgia
$755K +$683K +13,870 New
SCM
204
Snow Capital Management
Pennsylvania
$754K +$682K +13,850 New
SAM
205
Securian Asset Management
Minnesota
$753K +$681K +13,822 New
VW
206
Vantage Wealth
California
$749K +$678K +13,759 New
SAM
207
Symphony Asset Management
California
$748K +$677K +13,737 New
Bank of Montreal
208
Bank of Montreal
Ontario, Canada
$726K +$655K +13,300 New
Nomura Holdings
209
Nomura Holdings
Japan
$722K +$653K +13,252 New
PCM
210
Parsons Capital Management
Rhode Island
$698K +$632K +12,821 New
PPCM
211
Pillar Pacific Capital Management
California
$697K +$630K +12,797 New
WG
212
Winton Group
United Kingdom
$697K +$631K +12,803 New
Nomura Asset Management
213
Nomura Asset Management
Japan
$674K +$609K +12,369 New
Creative Planning
214
Creative Planning
Kansas
$656K +$593K +12,045 New
JMPWA
215
JP Morgan Private Wealth Advisors
California
$653K +$591K +11,990 New
M&T Bank
216
M&T Bank
New York
$646K +$584K +11,849 New
MC
217
Muhlenkamp & Co
Pennsylvania
$629K +$569K +11,543 New
HighTower Advisors
218
HighTower Advisors
Illinois
$624K +$583K +11,828 New
ProShare Advisors
219
ProShare Advisors
Maryland
$612K +$553K +11,235 New
Jane Street
220
Jane Street
New York
$607K +$549K +11,143 New
GCP
221
GSA Capital Partners
United Kingdom
$599K +$542K +10,996 New
HP
222
Hikari Power
Japan
$599K +$542K +11,000 New
GL
223
GLG LLC
New York
$592K +$535K +10,869 New
SLAM
224
Swiss Life Asset Management
$587K +$531K +10,779 New
TNB
225
Thomasville National Bank
Georgia
$579K +$524K +10,630 New
7 8
9
10 11

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.